ACXP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Acurx Pharmaceuticals Inc (ACXP) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows weak financial performance, no significant positive catalysts, and lacks clear trading signals. Additionally, technical indicators suggest a bearish trend, and there is no recent news or analyst activity to support a bullish outlook.
The stock is in a bearish trend with SMA_200 > SMA_20 > SMA_5. The MACD histogram is negative (-0.00732) and contracting, while RSI is neutral at 29.47. Key support levels are at 1.498 and 1.342, with resistance at 1.75 and 2.002. The stock closed at 1.61 with a 5.81% regular market gain but showed weakness in pre-market (-0.64%) and post-market (-1.83%).
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
Weak financial performance in Q3 2025 with a YoY net income drop of -29.37% and EPS decline of -64.35%. No recent congress trading data or analyst activity. Technical indicators suggest a bearish trend.
In Q3 2025, revenue remained at 0 with no growth YoY. Net income dropped to -1,992,790 (-29.37% YoY), and EPS fell to -1.23 (-64.35% YoY). Gross margin remained at 0 with no improvement.
No data available for analyst ratings or price target changes.
